sls-002
Generic: racemic ketamine
sls-002: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SEELOS THERAPEUTICS, INC. (SEEL) | Phase 2 |
Get deeper analysis on sls-002
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis